1 / 6

Migraine Pipeline Review Assessment H1 2015

This report gives broad information on the healing progression for Migraine, complete with comparable examination at diverse stages, therapeutics evaluation by pharmaceutical target, segment of action (MoA), course of association (RoA) and molecule sort, nearby latest upgrades, and highlighted news and press releases. It moreover reviews key players included in the supportive progression for Migraine and phenomenal segments on late-organize and stopped endeavours

john2222deere
Download Presentation

Migraine Pipeline Review Assessment H1 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Migraine - Pipeline Review, H1 2015 By RnRMarketResearch.com Publisher Name : Global Markets Direct Date: 24-Jun-2015 No. of pages: 199 Single User License: US $2000 Browse more Reports on Neurology therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/neurology-therapeutics . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Migraine - Pipeline Review, H1 2015 This report gives broad information on the healing progression for Migraine, complete with comparable examination at diverse stages, therapeutics evaluation by pharmaceutical target, segment of action (MoA), course of association (RoA) and molecule sort, nearby latest upgrades, and highlighted news and press releases. It moreover reviews key players included in the supportive progression for Migraine and phenomenal segments on late-organize and stopped endeavours. The report enhances decision making capacities and help to make convincing counter strategies to expand high ground. It strengthens R&D pipelines by perceiving new targets and MOAs to convey first-in-class and best-in-class things. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Migraine - Pipeline Review, H1 2015 Companies Discussed/Mentioned in this Research: Ache LaboratoriosFarmaceuticos S/A, Acorda Therapeutics, Inc., Alder Biopharmaceuticals Inc., Allergan, Inc., Amgen Inc., Astellas Pharma Inc., BioDelivery Sciences International, Inc., Biofrontera AG, Bristol-Myers Squibb Company, Charleston Laboratories, Inc., CoLucid Pharmaceuticals, Inc., D-Pharm Ltd., Dr. Reddy's Laboratories Limited, Eli Lilly and Company, Heptares Therapeutics Limited, iCeutica, Inc., Mallinckrodt Plc, Medestea Research & Production S.p.A and more Drugs Profile Discussed in this Research : dextromethorphan hydrobromide + quinidine sulfate), (naproxen sodium + naratriptan hydrochloride), (sumatriptan succinate + naproxen sodium), AA-71, ALD-403, AMG-334, BEMA Triptan, BF-1, C-012, CLH-1T, corticotropin, CVT-427, Deina, DFN-02, DFN-11, DFP-02, dihydroergotaminemesylate, dihydroergotaminemesylate, DORA-12, DP-VPA, esterol, histamine dihydrochloride and more ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Migraine - Pipeline Review, H1 2015 Scope For Migraine - Pipeline Review, H1 2015 • The report provides a snapshot of the global therapeutic landscape of Migraine • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Migraine and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • A review of the Migraine products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Migraine - Pipeline Review, H1 2015 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Migraine • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Migraine pipeline depth and focus of Indication therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Migraine - Pipeline Review, H1 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related